VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Feb 24, 2026
Document Date
Feb 23, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
HONORE TAGE
Copyright © 2005-2026 Vanda Pharmaceuticals Inc. |